Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032303 | SCV001195610 | likely pathogenic | not provided | 2019-07-23 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 38-56 of the USH2A gene. It preserves the integrity of the reading frame. This variant has been observed in an individual affected with Usher syndrome (PMID: 26927203). This variant disrupts the p.Thr3571 and p.Pro3272 amino acid residues in USH2A. Other variant(s) that disrupt these residues have been determined to be pathogenic (PMID: 17085681, 21569298, 28653555, 28894305, 18281613, 27157150, 26667666, 29142287, 26338283, 25575603). This suggests that these residues are clinically significant, and that variants that disrupt these residues are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |